LRRK2 Phosphorylates Neuronal Elav RNA-Binding Proteins to Regulate Phenotypes Relevant to Parkinson’s Disease

Parkinson’s disease (PD) is characterized by accumulation of α-synuclein and the loss of dopaminergic neurons. Mutations which cause an increase in the kinase activity of Leucine-Rich-Repeat Kinase-2 (LRRK2) are a major inherited cause of PD. Research continues to determine which targets LRRK2 phosphorylates to cause disease. Polymorphisms in the locus of ELAVL4, an RNA-binding protein are a risk-factor for Parkinson’s disease and an ELAV family member was identified in Drosophila as required for pathology instigated by human mutant LRRK2. We discovered that three neuronal ELAVs including ELAVL4 (also known as HuD) are phosphorylated by LRRK2. This controls binding of neuronal ELAVs to mRNA and their post- transcriptional regulation of mRNA abundance and splicing in neuronal cell lines and the mouse midbrain. LRRK2 G2019S functionally inhibits neuronal ELAVs effects on mRNA abundance, while enhancing their effects on mRNA splicing. The combination of LRRK2 G2019S and ELAVL4-/- causes accumulation of LRRK2 and α-synuclein, loss of dopaminergic neurons and motor deficits. Targets of neuronal ELAVs are also selectively misregulated in cells and tissues of PD patients. Together, this suggests that misregulation of neuronal ELAVs, triggered by LRRK2 mutations may contribute to the characteristic pathology of Parkinson’s disease. Brief Summary LRRK2, a kinase linked to Parkinson’s disease, phosphorylates the neuronal ELAV RNA-binding proteins to aggravate key hallmarks of Parkinson’s disease including accumulation of α-synuclein and motor deficits in mice.

[1]  D. Alessi,et al.  Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites , 2020, bioRxiv.

[2]  M. Cookson,et al.  Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo , 2020, Molecular Neurodegeneration.

[3]  D. Alessi,et al.  Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease , 2020, Current opinion in cell biology.

[4]  A. Singleton,et al.  Genetics of Parkinson's disease: An introspection of its journey towards precision medicine , 2020, Neurobiology of Disease.

[5]  M. Mann,et al.  Accurate MS-based Rab10 phosphorylation stoichiometry determination as readout for LRRK2 activity in Parkinson’s disease , 2019, bioRxiv.

[6]  S. Pfeffer,et al.  PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins , 2019, bioRxiv.

[7]  Gregor Bieri,et al.  LRRK2 modifies α-syn pathology and spread in mouse models and human neurons , 2019, bioRxiv.

[8]  S. Pfeffer,et al.  A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain , 2018, eLife.

[9]  A. Stepan,et al.  LRRK2 activation in idiopathic Parkinson’s disease , 2018, Science Translational Medicine.

[10]  G. Sanguinetti,et al.  HuD Is a Neural Translation Enhancer Acting on mTORC1-Responsive Genes and Counteracted by the Y3 Small Non-coding RNA , 2018, Molecular cell.

[11]  David S. Park,et al.  Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease , 2018, Proceedings of the National Academy of Sciences.

[12]  T. Dawson,et al.  Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration , 2018, Molecular Neurodegeneration.

[13]  Guodong Huang,et al.  Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice , 2017, Neuron.

[14]  M. Mann,et al.  Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase , 2017, The Biochemical journal.

[15]  Matthias Mann,et al.  Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis , 2017, eLife.

[16]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[17]  David S. Park,et al.  LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila , 2017, Human molecular genetics.

[18]  C. Webber,et al.  Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson’s disease , 2017, Human molecular genetics.

[19]  Raffaella Casadei,et al.  Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression , 2016, PloS one.

[20]  Avi Ma'ayan,et al.  Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain , 2016, eLife.

[21]  Matthias Mann,et al.  Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases , 2016, eLife.

[22]  S. Lincoln,et al.  Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice , 2015, Neurobiology of Disease.

[23]  Baoji Xu,et al.  HuD Interacts with Bdnf mRNA and Is Essential for Activity-Induced BDNF Synthesis in Dendrites , 2015, PloS one.

[24]  Amaia M. Arranz,et al.  LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism , 2015, Journal of Cell Science.

[25]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[26]  M. Kumar,et al.  Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson’s Disease , 2014, Cell.

[27]  H. Okano,et al.  Prenatal Deletion of the RNA-Binding Protein HuD Disrupts Postnatal Cortical Circuit Maturation and Behavior , 2014, The Journal of Neuroscience.

[28]  Z. Fei,et al.  Homer1 knockdown protects dopamine neurons through regulating calcium homeostasis in an in vitro model of Parkinson's disease. , 2013, Cellular signalling.

[29]  M. Gorospe,et al.  The RNA-binding Protein HuD Regulates Autophagosome Formation in Pancreatic β Cells by Promoting Autophagy-related Gene 5 Expression* , 2013, The Journal of Biological Chemistry.

[30]  B. Jasmin,et al.  Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction , 2013, RNA.

[31]  A. Consiglio,et al.  Interplay of LRRK2 with chaperone-mediated autophagy , 2013, Nature Neuroscience.

[32]  N. Perrone-Bizzozero,et al.  HuD Promotes BDNF Expression in Brain Neurons via Selective Stabilization of the BDNF Long 3′UTR mRNA , 2013, PloS one.

[33]  D. Alkon,et al.  Protein kinase C stimulates HuD‐mediated mRNA stability and protein expression of neurotrophic factors and enhances dendritic maturation of hippocampal neurons in culture , 2012, Hippocampus.

[34]  J. Yates,et al.  Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 , 2012, Nature.

[35]  A. Mele,et al.  Neuronal Elav-like (Hu) Proteins Regulate RNA Splicing and Abundance to Control Glutamate Levels and Neuronal Excitability , 2012, Neuron.

[36]  E. Mercken,et al.  RNA-binding protein HuD controls insulin translation. , 2012, Molecular cell.

[37]  J. Keene,et al.  Neuron-specific ELAV/Hu proteins suppress HuR mRNA during neuronal differentiation by alternative polyadenylation , 2011, Nucleic acids research.

[38]  C. Schnell,et al.  LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice , 2011, Human molecular genetics.

[39]  Y. Liu,et al.  Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2 , 2011, PloS one.

[40]  N. Sokol,et al.  Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression , 2010, Nature.

[41]  R. Burke,et al.  Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.

[42]  H. Firth,et al.  Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression , 2010, Human mutation.

[43]  Kunio Inoue,et al.  The ELAV protein HuD stimulates cap-dependent translation in a Poly(A)- and eIF4A-dependent manner. , 2009, Molecules and Cells.

[44]  H. Cai,et al.  Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein , 2009, Neuron.

[45]  N. Perrone-Bizzozero,et al.  Novel recognition motifs and biological functions of the RNA-binding protein HuD revealed by genome-wide identification of its targets , 2009, Nucleic acids research.

[46]  M. Caron,et al.  Activity‐dependent expression of ELAV/Hu RBPs and neuronal mRNAs in seizure and cocaine brain , 2008, Journal of neurochemistry.

[47]  R. Takahashi,et al.  Phosphorylation of 4E‐BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila , 2008, The EMBO journal.

[48]  Mi-Sung Kim,et al.  MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function , 2008, Proceedings of the National Academy of Sciences.

[49]  Christine Klein,et al.  Replication of association between ELAVL4 and Parkinson disease: the GenePD study , 2008, Human Genetics.

[50]  M. Farrer,et al.  ELAVL4, PARK10, and the Celts , 2007, Movement disorders : official journal of the Movement Disorder Society.

[51]  L. Behar,et al.  Dynamic association with polysomes during P19 neuronal differentiation and an untranslated‐region‐dependent translation regulation of the tau mRNA by the tau mRNA‐associated proteins IMP1, HuD, and G3BP1 , 2007, Journal of neuroscience research.

[52]  C. Ross,et al.  Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Blackshear,et al.  HuR as a negative posttranscriptional modulator in inflammation. , 2005, Molecular cell.

[54]  D. Alkon,et al.  Neuronal ELAV proteins enhance mRNA stability by a PKCalpha-dependent pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Pericak-Vance,et al.  Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease , 2005, Human Genetics.

[56]  H. Okano,et al.  Involvement of Hu and Heterogeneous Nuclear Ribonucleoprotein K in Neuronal Differentiation through p21 mRNA Post-transcriptional Regulation* , 2005, Journal of Biological Chemistry.

[57]  H. Okano,et al.  The RNA-binding protein HuD regulates neuronal cell identity and maturation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[59]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[60]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[61]  P. Worley,et al.  Homer Proteins Regulate Sensitivity to Cocaine , 2004, Neuron.

[62]  I. Laird-Offringa,et al.  HuD RNA Recognition Motifs Play Distinct Roles in the Formation of a Stable Complex with AU-Rich RNA , 2004, Molecular and Cellular Biology.

[63]  L. Hengst,et al.  ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR. , 2002, Genes & development.

[64]  N. Perrone-Bizzozero,et al.  Poly(A) Tail Length-dependent Stabilization of GAP-43 mRNA by the RNA-binding Protein HuD* , 2002, The Journal of Biological Chemistry.

[65]  R. Nussbaum,et al.  Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. , 2001, Human molecular genetics.

[66]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[67]  R. Darnell,et al.  Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Sang-Ho Chung,et al.  Embryonic Lethal Abnormal Vision-Like RNA-Binding Proteins Regulate Neurite Outgrowth and Tau Expression in PC12 Cells , 1999, The Journal of Neuroscience.

[69]  B. Joseph,et al.  p21waf1 mRNA Contains a Conserved Element in Its 3′-Untranslated Region That Is Bound by the Elav-like mRNA-stabilizing Proteins* , 1998, The Journal of Biological Chemistry.

[70]  R. Darnell,et al.  A Hierarchy of Hu RNA Binding Proteins in Developing and Adult Neurons , 1997, The Journal of Neuroscience.

[71]  S. Cheng,et al.  Purification and Properties of HuD, a Neuronal RNA-binding Protein (*) , 1996, The Journal of Biological Chemistry.

[72]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[73]  U Inserm,et al.  Causal relation between α synuclein gene duplication and familial Parkinson’s disease , 2005 .